First-line ribociclib plus letrozole in HR+, HER2-ABC: Efficacy by baseline tumor markers

Affiliation auteurs!!!! Error affiliation !!!!
TitreFirst-line ribociclib plus letrozole in HR+, HER2-ABC: Efficacy by baseline tumor markers
Type de publicationJournal Article
Year of Publication2017
AuteursCampone M., Marschner N., Villanueva C., Sonke G.S, Alba E., Jakobsen E., Su F., He W., Germa C., Andre F.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedMAY
Type of ArticleMeeting Abstract
ISSN0923-7534